PATENT CLAIM ANALYSIS

Application Number: 16106582
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "162000"]

Abstract:
The disclosure provides methods and compositions for treating skin conditions. In particular, the disclosure provides compositions comprising metformin either alone or in combination with at least one additional active agent, and methods for treating skin conditions using such compositions.

Claim (Index 14):
The composition of  claim 2 , wherein the composition comprises a beta-blocker, wherein the beta-blocker is selected from the group consisting of carvediol, propranolol, and timolol.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11365764', '13364547', '15271103', '14899255', '15269792']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7679292549228244
- 35 USC 102 Novelty (BERT): 0.5106094563613627
- Combined Prediction Score: 0.7421972750666782
- Mean Citation Score: 169.63155799999996
- Max Citation Score: 178.97893
- Similarity Product: 92.65688295106943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test